(Q51079328)

28 March 2018

title

Mecamylamine blockade of both positive and negative effects of IV nicotine in human volunteers. (English)

1 reference

28 March 2018

0 references

Lundahl LH

1

1 reference

28 March 2018

Henningfield JE

series ordinal

2

1 reference

28 March 2018

Lukas SE

series ordinal

3

1 reference

28 March 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

28 March 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

28 March 2018

volume

66

1 reference

28 March 2018

issue

3

1 reference

28 March 2018

page(s)

637-643

1 reference

28 March 2018

Nicotine and carbon monoxide intake from high- and low-yield cigarettes.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Cigarette smokers self-administer intravenous nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Nicotine as a reinforcer in human subjects and laboratory animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Control of behavior by intravenous nicotine injections in human subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Recent studies of nicotine metabolism in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Effects of mecamylamine on human cigarette smoking and subjective ratings

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Comparison of acute subjective and heart rate effects of nicotine intake via tobacco smoking versus nasal spray

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Mecamylamine reduces some EEG effects of nicotine chewing gum in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Mecamylamine pretreatment increases subsequent nicotine self-administration as indicated by changes in plasma nicotine level

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Combined Administration of Agonist‐Antagonist as a Method of Regulating Receptor Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Blockade of smoking satisfaction using the peripheral nicotinic antagonist trimethaphan

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Combined effects of nicotine and mecamylamine in attenuating smoking satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Could nicotine antagonists be used in smoking cessation?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

Influencing cigarette smoking with nicotine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900252-5

7 January 2021

10.1016/S0091-3057(00)00252-5

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018